Research statistics

Terlipressin research: publications and trials

What has been published on Terlipressin: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Terlipressin works or is safe. For what it is and what the studies found, see the Terlipressin profile.
Automated weekly refresh · data through November 1, 2026

At a glance

Publications, all years

1,125

Since 1976

Publications in 2026 so far

32

Through November 1, 2026

Human clinical research

45.8%

502 of 1,097 classified

Registered clinical trials

95

ClinicalTrials.gov

Randomized controlled trials

153

Publications reporting an RCT in people

Systematic reviews and meta-analyses

80

Preclinical studies

10.6%

95 animal · 10 in vitro · 11 computational

Records that only mention it

250

Not counted above

Status in the library: FDA-approved. 28 publications are not yet classified by study type.

What to keep in mind

  • Some completed trials have neither posted results nor a linked results publication.

Publications by year

Terlipressin publications by year and evidence

1976, Human clinical research: 1 of 11977, Human clinical research: 1 of 11978, Human clinical research: 1 of 11979, Human clinical research: 1 of 11980, Human clinical research: 4 of 61980, Preclinical (animal, in vitro, computational): 1 of 61980, Other and not yet classified: 1 of 61982, Human clinical research: 2 of 31982, Other and not yet classified: 1 of 31983, Preclinical (animal, in vitro, computational): 2 of 31983, Reviews and meta-analyses: 1 of 31984, Human clinical research: 1 of 41984, Preclinical (animal, in vitro, computational): 3 of 41985, Human clinical research: 3 of 61985, Preclinical (animal, in vitro, computational): 2 of 61985, Other and not yet classified: 1 of 61986, Human clinical research: 6 of 111986, Reviews and meta-analyses: 2 of 111986, Other and not yet classified: 3 of 111987, Human clinical research: 4 of 71987, Preclinical (animal, in vitro, computational): 1 of 71987, Reviews and meta-analyses: 1 of 71987, Other and not yet classified: 1 of 71988, Human clinical research: 4 of 61988, Preclinical (animal, in vitro, computational): 1 of 61988, Reviews and meta-analyses: 1 of 61989, Human clinical research: 6 of 81989, Preclinical (animal, in vitro, computational): 1 of 81989, Other and not yet classified: 1 of 81990, Human clinical research: 10 of 141990, Preclinical (animal, in vitro, computational): 2 of 141990, Reviews and meta-analyses: 2 of 141991, Human clinical research: 5 of 81991, Reviews and meta-analyses: 3 of 81992, Human clinical research: 3 of 61992, Preclinical (animal, in vitro, computational): 1 of 61992, Reviews and meta-analyses: 2 of 61993, Human clinical research: 7 of 111993, Preclinical (animal, in vitro, computational): 2 of 111993, Reviews and meta-analyses: 1 of 111993, Other and not yet classified: 1 of 111994, Human clinical research: 4 of 91994, Reviews and meta-analyses: 3 of 91994, Other and not yet classified: 2 of 91995, Human clinical research: 2 of 101995, Preclinical (animal, in vitro, computational): 2 of 101995, Reviews and meta-analyses: 4 of 101995, Other and not yet classified: 2 of 101996, Human clinical research: 8 of 111996, Preclinical (animal, in vitro, computational): 1 of 111996, Other and not yet classified: 2 of 111997, Human clinical research: 6 of 131997, Preclinical (animal, in vitro, computational): 2 of 131997, Reviews and meta-analyses: 3 of 131997, Other and not yet classified: 2 of 131998, Human clinical research: 3 of 151998, Preclinical (animal, in vitro, computational): 4 of 151998, Reviews and meta-analyses: 7 of 151998, Other and not yet classified: 1 of 151999, Human clinical research: 7 of 181999, Preclinical (animal, in vitro, computational): 5 of 181999, Reviews and meta-analyses: 3 of 181999, Other and not yet classified: 3 of 182000, Human clinical research: 6 of 162000, Preclinical (animal, in vitro, computational): 3 of 162000, Reviews and meta-analyses: 6 of 162000, Other and not yet classified: 1 of 162001, Human clinical research: 5 of 162001, Preclinical (animal, in vitro, computational): 4 of 162001, Reviews and meta-analyses: 5 of 162001, Other and not yet classified: 2 of 162002, Human clinical research: 12 of 212002, Preclinical (animal, in vitro, computational): 2 of 212002, Reviews and meta-analyses: 4 of 212002, Other and not yet classified: 3 of 212003, Human clinical research: 9 of 242003, Preclinical (animal, in vitro, computational): 2 of 242003, Reviews and meta-analyses: 9 of 242003, Other and not yet classified: 4 of 242004, Human clinical research: 19 of 352004, Preclinical (animal, in vitro, computational): 2 of 352004, Reviews and meta-analyses: 10 of 352004, Other and not yet classified: 4 of 352005, Human clinical research: 10 of 212005, Preclinical (animal, in vitro, computational): 3 of 212005, Reviews and meta-analyses: 4 of 212005, Other and not yet classified: 4 of 212006, Human clinical research: 15 of 352006, Preclinical (animal, in vitro, computational): 1 of 352006, Reviews and meta-analyses: 15 of 352006, Other and not yet classified: 4 of 352007, Human clinical research: 19 of 362007, Preclinical (animal, in vitro, computational): 2 of 362007, Reviews and meta-analyses: 6 of 362007, Other and not yet classified: 9 of 362008, Human clinical research: 15 of 342008, Preclinical (animal, in vitro, computational): 1 of 342008, Reviews and meta-analyses: 14 of 342008, Other and not yet classified: 4 of 342009, Human clinical research: 17 of 372009, Preclinical (animal, in vitro, computational): 4 of 372009, Reviews and meta-analyses: 5 of 372009, Other and not yet classified: 11 of 372010, Human clinical research: 23 of 382010, Preclinical (animal, in vitro, computational): 2 of 382010, Reviews and meta-analyses: 11 of 382010, Other and not yet classified: 2 of 382011, Human clinical research: 20 of 402011, Preclinical (animal, in vitro, computational): 3 of 402011, Reviews and meta-analyses: 10 of 402011, Other and not yet classified: 7 of 402012, Human clinical research: 13 of 302012, Preclinical (animal, in vitro, computational): 3 of 302012, Reviews and meta-analyses: 10 of 302012, Other and not yet classified: 4 of 302013, Human clinical research: 18 of 322013, Preclinical (animal, in vitro, computational): 3 of 322013, Reviews and meta-analyses: 10 of 322013, Other and not yet classified: 1 of 322014, Human clinical research: 11 of 272014, Preclinical (animal, in vitro, computational): 5 of 272014, Reviews and meta-analyses: 4 of 272014, Other and not yet classified: 7 of 272015, Human clinical research: 19 of 332015, Preclinical (animal, in vitro, computational): 3 of 332015, Reviews and meta-analyses: 8 of 332015, Other and not yet classified: 3 of 332016, Human clinical research: 14 of 332016, Preclinical (animal, in vitro, computational): 5 of 332016, Reviews and meta-analyses: 8 of 332016, Other and not yet classified: 6 of 332017, Human clinical research: 16 of 392017, Preclinical (animal, in vitro, computational): 5 of 392017, Reviews and meta-analyses: 12 of 392017, Other and not yet classified: 6 of 392018, Human clinical research: 12 of 322018, Preclinical (animal, in vitro, computational): 4 of 322018, Reviews and meta-analyses: 6 of 322018, Other and not yet classified: 10 of 322019, Human clinical research: 19 of 492019, Preclinical (animal, in vitro, computational): 2 of 492019, Reviews and meta-analyses: 18 of 492019, Other and not yet classified: 10 of 492020, Human clinical research: 16 of 432020, Preclinical (animal, in vitro, computational): 6 of 432020, Reviews and meta-analyses: 11 of 432020, Other and not yet classified: 10 of 432021, Human clinical research: 13 of 382021, Preclinical (animal, in vitro, computational): 4 of 382021, Reviews and meta-analyses: 10 of 382021, Other and not yet classified: 11 of 382022, Human clinical research: 13 of 282022, Preclinical (animal, in vitro, computational): 3 of 282022, Reviews and meta-analyses: 7 of 282022, Other and not yet classified: 5 of 282023, Human clinical research: 18 of 602023, Preclinical (animal, in vitro, computational): 4 of 602023, Reviews and meta-analyses: 21 of 602023, Other and not yet classified: 17 of 602024, Human clinical research: 18 of 622024, Preclinical (animal, in vitro, computational): 2 of 622024, Reviews and meta-analyses: 15 of 622024, Other and not yet classified: 27 of 622025, Human clinical research: 25 of 612025, Preclinical (animal, in vitro, computational): 5 of 612025, Reviews and meta-analyses: 15 of 612025, Other and not yet classified: 16 of 612026 (to date), Human clinical research: 18 of 322026 (to date), Preclinical (animal, in vitro, computational): 3 of 322026 (to date), Reviews and meta-analyses: 5 of 322026 (to date), Other and not yet classified: 6 of 32Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified020406080197619871997200720172026*
Counted PubMed publications by year of first publication. * 2026 runs to November 1, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
197610001
197710001
197810001
197910001
198041016
198220013
198302103
198413004
198532016
1986602311
198741117
198841106
198961018
19901022014
199150308
199231206
1993721111
199440329
1995224210
1996810211
1997623213
1998347115
1999753318
2000636116
2001545216
20021224321
2003929424
200419210435
20051034421
200615115435
20071926936
200815114434
200917451137
201023211238
201120310740
201213310430
201318310132
20141154727
20151938333
20161458633
201716512639
201812461032
2019192181049
2020166111043
2021134101138
20221337528
2023184211760
2024182152762
2025255151661
2026 (to date)1835632

Study types

Review212
Editorial, letter or other176
Case report157
Randomized controlled trial153
Observational human study110
Animal study95
Other clinical trial82
Meta-analysis55
Not yet classified28
Systematic review25
Computational study11
In vitro study10
Guideline or consensus7
Correction or retraction notice4

Research areas

From MeSH major topics. A paper can be in several areas.

Gastrointestinal704
Reproductive and sexual health340
Cardiovascular294
Immune system118
Antimicrobial and infectious disease113
Endocrinology58
Metabolic health52
Tissue repair48
Dermatology25
Neurological and mental health23
Oncology15
Musculoskeletal10

Registered clinical trials

22 of 46 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 49 · Unknown status: 29 · Terminated: 5 · Recruiting: 4 · Not yet recruiting: 3 · Active, not recruiting: 2 · Withdrawn: 2 · Suspended: 1
Phase not applicable: 35 · Phase 1: 2 · Phase 1 / Phase 2: 1 · Phase 2: 15 · Phase 2 / Phase 3: 7 · Phase 3: 16 · Phase 4: 19

TrialStatusPhaseStartedResults
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal DysfunctionNCT07252401 · 64 enrolledNot yet recruitingPhase not applicable2026-09—
Terlipressin vs Placebo to Reduce Bleeding in Fibroid SurgeryNCT07746349 · 80 enrolledNot yet recruitingPhase not applicable2026-08—
Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver TransplantationNCT07304466 · 50 enrolledRecruitingPhase not applicable2025-12—
Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal SyndromeNCT07460908 · 60 enrolledCompletedPhase not applicable2025-05—
Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney TransplantationNCT06855758 · 150 enrolledActive, not recruitingPhase not applicable2025-03—
Efficacy and Safety of Continuous Infusion of Terlipressin vs Bolus Terlipressin in ACLF Patients With Acute Esophageal Variceal BleedNCT06815770 · 60 enrolledNot yet recruitingPhase 2, Phase 32025-02—
Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic ShockNCT06556472 · 126 enrolledUnknown statusPhase not applicable2024-08—
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver CirrhosisNCT03130127 · 40 enrolledUnknown statusPhase not applicable2024-07—
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal SyndromeNCT06256432 · 54 enrolledActive, not recruitingPhase 22024-04—
Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort StudyNCT07719933 · 161 enrolledCompletedPhase not applicable2024-04—
Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal DiseaseNCT06161766 · 490 enrolledCompletedPhase not applicable2024-03—
Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation PatientsNCT06108362 · 104 enrolledCompletedPhase 42023-10—
Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal LigationNCT06027970 · 165 enrolledUnknown statusPhase 32023-09—
Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal SyndromeNCT05875948 · 95 enrolledUnknown statusPhase 22023-06—
Methods Decreasing Bleeding in Open MyomectomyNCT05806307 · 105 enrolledUnknown statusPhase 42023-03—
Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee ArthroplastyNCT05774067 · 135 enrolledCompletedPhase not applicable2022-12—
HRS-AKI Treatment With TIPS in Patients With CirrhosisNCT05346393 · 124 enrolledRecruitingPhase not applicable2022-11—
Clinical Trial Comparing Noradrenaline (NA) Plus Placebo Versus Noradrenaline Plus Terlipressin (TP) in Septic ShockNCT05207280 · 152 enrolledUnknown statusPhase 32022-10—
Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C TrialNCT05315557 · 100 enrolledUnknown statusPhase not applicable2022-04—
ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.NCT04961528 · 315 enrolledCompletedPhase 32022-03—
The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy OperationsNCT05154279 · 99 enrolledUnknown statusPhase not applicable2022-02—
The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy OperationsNCT05170230 · 99 enrolledUnknown statusPhase not applicable2022-02—
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:NCT05242783 · 99 enrolledCompletedPhase not applicable2022-02—
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver CirrhoticsNCT05490888 · 74 enrolledRecruitingPhase 12022-01—
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic TourniquetsNCT05266534 · 162 enrolledRecruitingPhase not applicable2021-12—
Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic PatientsNCT05080543 · 36 enrolledUnknown statusPhase 12021-10—
Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.NCT04819568 · 310 enrolledUnknown statusPhase not applicable2021-06—
A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory AscitesNCT04112199 · 15 enrolledTerminatedPhase 22021-06—
Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin TherapyNCT05331768 · 109 enrolledCompletedPhase not applicable2021-01—
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)NCT04460560 · 50 enrolledCompletedPhase 32020-12Posted
Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.NCT04416282 · 70 enrolledCompletedPhase not applicable2020-06—
Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.NCT04353193 · 36 enrolledUnknown statusPhase 42020-06—
Terlipressin for Refractory Septic ShockNCT04339868 · 130 enrolledUnknown statusPhase 22020-04—
Does Terlipressin Improve Renal Outcome After Liver SurgeryNCT02368249WithdrawnPhase 22020-01—
The Effect of Terlipressin on Recovery of Liver Function After HepatectomyNCT04221672 · 86 enrolledUnknown statusPhase 32019-11—
Effects of Terlipressin on Renal Perfusion in Patients With Septic ShockNCT04948372 · 22 enrolledCompletedPhase not applicable2019-09—
2- Day vs. 5- Day Terlipressin and Ceftriaxone in the Control Acute Gastroesophageal Variceal HemorrhageNCT04056806 · 100 enrolledUnknown statusPhase 42019-08—
Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)NCT04028323 · 60 enrolledUnknown statusPhase 42019-07—
Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal HemorrhageNCT03846180 · 1,682 enrolledCompletedPhase not applicable2019-03—
Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm NeonateNCT04110418 · 36 enrolledUnknown statusPhase 22019-02—
Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1NCT03822091 · 60 enrolledCompletedPhase 32019-01—
Terlipressin Infusion in Variceal HemorrhageNCT04028505 · 128 enrolledUnknown statusPhase 32018-10—
Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor StudyNCT03336814 · 40 enrolledUnknown statusPhase 42018-07—
Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study.NCT03608514 · 100 enrolledUnknown statusPhase 2, Phase 32018-07—
Efficacy of Terlipressin Therapy in Acute Variceal Haemorrhage After EVLNCT03584087 · 74 enrolledCompletedPhase 42018-05—
Effect of Terlipressin on Cerebral Oxygen Saturation During Liver TransplantationNCT03395574 · 30 enrolledCompletedPhase 22018-01—
Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal BleedingNCT04358016 · 54 enrolledCompletedPhase 42018-01—
Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory AscitesNCT03107091 · 6 enrolledCompletedPhase 22017-07Posted
Interest of in Situ Terlipressin Administration Before the Realisation of Bronchial BiopsyNCT02970175 · 130 enrolledCompletedPhase 32017-06—
Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in CirrhosisNCT03144713 · 150 enrolledCompletedPhase not applicable2017-05—

The 50 most recently started of 95 trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Continuous Versus Bolus Terlipressin for Acute Oesophageal Variceal Bleeding and Hepatorenal Syndrome in Cirrhosis: Meta-Analysis.

    Liver international : official journal of the International Association for the Study of the Liver · April 1, 2026 · Meta-analysis · cited 0 times

    PMID 41853888 · DOI 10.1111/liv.70607 · Reviews and meta-analyses

  2. Efficacy and safety of terlipressin infusion during liver surgery: a meta-analysis.

    Updates in surgery · April 16, 2025 · Meta-analysis · cited 1 times · open access

    PMID 40240682 · DOI 10.1007/s13304-025-02197-y · Reviews and meta-analyses

  3. Terlipressin for the treatment of hepatorenal syndrome: a meta-analysis of randomized controlled trials.

    European journal of gastroenterology & hepatology · February 27, 2025 · Meta-analysis · cited 3 times

    PMID 40207491 · DOI 10.1097/meg.0000000000002954 · Reviews and meta-analyses

  4. Incidence and type of adverse events in patients with cirrhosis receiving terlipressin: A systematic review and meta-analysis.

    Hepatology communications · September 18, 2024 · Meta-analysis · cited 8 times · open access

    PMID 39298544 · DOI 10.1097/hc9.0000000000000526 · Reviews and meta-analyses

  5. The effect of shortening vasoactive drug durations alongside endoscopic therapy in esophageal variceal bleeding: an updated systematic review and meta-analysis.

    Annals of gastroenterology · August 19, 2024 · Meta-analysis · cited 1 times · open access

    PMID 39238793 · DOI 10.20524/aog.2024.0906 · Reviews and meta-analyses

  6. Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis.

    Annals of hepatology · March 7, 2024 · Meta-analysis · cited 8 times · open access

    PMID 38460713 · DOI 10.1016/j.aohep.2024.101495 · Reviews and meta-analyses

  7. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.

    PloS one · January 29, 2024 · Meta-analysis · cited 17 times · open access

    PMID 38285703 · DOI 10.1371/journal.pone.0296690 · Reviews and meta-analyses

  8. Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies.

    Gastro hep advances · January 18, 2023 · Meta-analysis · cited 10 times · open access

    PMID 39132033 · DOI 10.1016/j.gastha.2023.01.007 · Reviews and meta-analyses

  9. Prophylactic Perioperative Terlipressin Therapy for Preventing Acute Kidney Injury in Living Donor Liver Transplant Recipients: A Systematic Review and Meta-Analysis.

    Journal of clinical and experimental hepatology · June 25, 2021 · Meta-analysis · cited 7 times · open access

    PMID 35535072 · DOI 10.1016/j.jceh.2021.06.019 · Reviews and meta-analyses

  10. Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis.

    Journal of gastrointestinal and liver diseases : JGLD · March 13, 2021 · Meta-analysis · cited 37 times · open access

    PMID 33723542 · DOI 10.15403/jgld-3191 · Reviews and meta-analyses

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

    Gut · March 27, 2007 · Review · cited 1,085 times · open access

    PMID 17389705 · DOI 10.1136/gut.2006.107789 · Reviews and meta-analyses

  2. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

    Gastroenterology · February 13, 2008 · Randomized controlled trial · cited 664 times · open access

    PMID 18471513 · DOI 10.1053/j.gastro.2008.02.014 · Human clinical research

  3. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

    Hepatology (Baltimore, Md.) · October 1, 2002 · Other clinical trial · cited 602 times · open access

    PMID 12297842 · DOI 10.1053/jhep.2002.35819 · Human clinical research

  4. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

    Gastroenterology · February 14, 2008 · Randomized controlled trial · cited 601 times

    PMID 18471512 · DOI 10.1053/j.gastro.2008.02.024 · Human clinical research

  5. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.

    The New England journal of medicine · March 1, 2021 · Randomized controlled trial · cited 484 times · open access

    PMID 33657294 · DOI 10.1056/nejmoa2008290 · Human clinical research

Latest publications

  1. Influence of Albumin Treatment Duration on Outcome of Terlipressin Therapy in Patients With HRS-AKI.

    Liver international : official journal of the International Association for the Study of the Liver · November 1, 2026 · Observational human study · cited 0 times · open access

    PMID 42813964 · DOI 10.1111/liv.70888 · Human clinical research

  2. Vasoconstrictor therapy for HRS-AKI in patients listed for liver transplantation: Translating evidence to the pretransplant setting.

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · October 2, 2026 · Systematic review · cited 0 times

    PMID 42825583 · DOI 10.1097/lvt.0000000000001012 · Reviews and meta-analyses

  3. Complete Response Durability After TAR-200 and Nadofaragene Firadenovec in BCG-unresponsive Bladder CIS.

    Anticancer research · October 1, 2026 · Computational study · cited 0 times

    PMID 42823172 · DOI 10.21873/anticanres.18415 · Computational studies

  4. Clinical Outcomes of Terlipressin Using Continuous Infusion Versus Bolus in Patients With Acute Variceal Hemorrhage-A Randomized Controlled Trial: Erratum.

    Journal of clinical gastroenterology · October 1, 2026 · Editorial, letter or other · cited 0 times

    PMID 42693530 · DOI 10.1097/mcg.0000000000002430 · Commentary and other

  5. Acute variceal bleeding in a patient with phaeochromocytoma: the critical choice of vasoactive therapy.

    BMJ case reports · September 30, 2026 · Case report · cited 0 times

    PMID 42816107 · DOI 10.1136/bcr-2026-272756 · Human clinical research

  6. Correction to "Terlipressin Therapy for Portal Hyperperfusion Secondary to Portal Vein Size Discrepancy After Pediatric Liver Transplant".

    Pediatric transplantation · September 1, 2026 · Correction or retraction notice · cited 0 times · open access

    PMID 42746863 · DOI 10.1111/petr.70399 · Notices

  7. Nonintensive Care Unit Norepinephrine as an Alternative to Terlipressin in Hepatorenal Syndrome-Acute Kidney Injury.

    Gastro hep advances · August 12, 2026 · Observational human study · cited 0 times · open access

    PMID 42757064 · DOI 10.1016/j.gastha.2026.101096 · Human clinical research

  8. Real-world safety of terlipressin in elderly patients with liver cirrhosis and esophagogastric variceal bleeding: a focus on hyponatremia and administration methods.

    Frontiers in pharmacology · August 3, 2026 · Observational human study · cited 0 times · open access

    PMID 42609465 · DOI 10.3389/fphar.2026.1861406 · Human clinical research

  9. Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.

    The Analyst · July 27, 2026 · In vitro study · cited 0 times

    PMID 42328738 · DOI 10.1039/d6an00455e · In vitro studies

  10. Evaluation of Terlipressin and In-Hospital Mortality in the Treatment of Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI).

    The Annals of pharmacotherapy · July 25, 2026 · Observational human study · cited 0 times · open access

    PMID 42500941 · DOI 10.1177/10600280261467017 · Human clinical research

Browse all 1,125 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Glypressin; Lucassin; Terlipresina; Terlipressin; Terlipressina; Terlipressine; Terlivaz; Triglycyl lysine vasopressin; Variquel

((TITLE_ABS:"Glypressin" OR CHEM:"Glypressin") OR (TITLE_ABS:"Lucassin" OR CHEM:"Lucassin") OR (TITLE_ABS:"Terlipresina" OR CHEM:"Terlipresina") OR (TITLE_ABS:"Terlipressin" OR CHEM:"Terlipressin") OR (TITLE_ABS:"Terlipressina" OR CHEM:"Terlipressina") OR (TITLE_ABS:"Terlipressine" OR CHEM:"Terlipressine") OR (TITLE_ABS:"Terlivaz" OR CHEM:"Terlivaz") OR (TITLE_ABS:"Triglycyl lysine vasopressin" OR CHEM:"Triglycyl lysine vasopressin") OR (TITLE_ABS:"Variquel" OR CHEM:"Variquel")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 2). Terlipressin research statistics (Version weekly-2026-11-01) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/terlipressin